To sign up to the Graham Hancock newsletter mailing list, please click here.
Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.
The nanoparticles were designed to sense glucose levels in the body and respond by secreting the appropriate amount of insulin, thereby replacing the function of pancreatic islet cells, which are destroyed in patients with Type 1 diabetes. Ultimately, this type of system could ensure that blood-sugar levels remain balanced and improve patientsí quality of life, according to the researchers.
Back to Previous...
Go to News Desk...
Enjoy the newsdesk? Please tell others about it:Tweet
Dedicated Servers and Cloud Servers by Gigenet. Invert Colour Scheme / Default